Cargando…
Novel 11-Substituted Ellipticines as Potent Anticancer Agents with Divergent Activity against Cancer Cells
Ellipticines have well documented anticancer activity, in particular with substitution at the 1-, 2-, 6- and 9-positions. However, due to limitations in synthesis and coherent screening methodology the full SAR profile of this anticancer class has not yet been achieved. In order to address this shor...
Autores principales: | Miller, Charlotte M., O’Sullivan, Elaine C., McCarthy, Florence O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631919/ https://www.ncbi.nlm.nih.gov/pubmed/31207878 http://dx.doi.org/10.3390/ph12020090 |
Ejemplares similares
-
Synthesis and Evaluation of Novel Ellipticines and Derivatives as Inhibitors of Phytophthora infestans
por: McKee, Mary L., et al.
Publicado: (2020) -
Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine
por: Ma, Weina, et al.
Publicado: (2012) -
The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells
por: Poljaková, Jitka, et al.
Publicado: (2008) -
Anticancer and Immunomodulatory Activities of a Novel Water-Soluble Derivative of Ellipticine
por: Costa de Oliveira, Regiane, et al.
Publicado: (2020) -
Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo
por: Wu, Yan, et al.
Publicado: (2012)